- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03434496
Music Role in PD Rehabilitation
The Role of Music in Improving Gait Abnormalities in Parkinson Disease
Neurologic Music Therapy (NMT) sensorimotor techniques are increasingly used to improve spatio-temporal gait parameters and postural stability in the course of Parkinson's Disease and following stroke. Nonetheless, the neurophysiological underpinnings of NMT-mediated gait recovery is still poorly understood.
The aim of the study was to investigate the central mechanisms of connectivity related to the application of Rhythmic Auditory Stimulation (RAS) in PD gait rehabilitation. The investigators will enroll 30 patients with PD. They will be randomized into two groups: (A) gait training with Music; (B) conventional treadmill gait training. The experimental group will perform training by means of GT3 (Biodex), where the patient is able to walk (on a treadmill) following specific musical beets and rhythms. The control group will perform only gait treadmill training.
Subjects will attend 3 sessions a week for at least 4 weeks. Each session will last 45-min.
Study Overview
Detailed Description
The aim of the study was to investigate the central mechanisms of connectivity related to the application of Rhythmic Auditory Stimulation (RAS) in PD gait rehabilitation. The investigators will enroll 30 patients with PD. They will be randomized into two groups: (A) gait training with Music; (B) conventional treadmill gait training. The experimental group will perform training by means of GT3 (Biodex), where the patient is able to walk (on a treadmill) following specific musical beets and rhythms. The control group will perform only gait treadmill training.
Subjects will attend 3 sessions a week for at least 4 weeks. Each session will last 45-min.
The investigators will assess the gait performance and pattern by using System BTS Smart for gait and the sensorimotor functional connectivity by using EEG, both before and after the therapy cycle. The patients will be clinically evaluated by means of Time up and go test, and ten meters. The overall motor function will be evaluated through the UPDRS III.
Power calculation by Cohen (1992) methodology will be utilized for this pilot study. Shapiro-Wilk test was applied to assess the normality of distribution. Thus, parametric and non-parametric tests will be employed for all comparisons (Wilcoxon test, ANOVA). Mann-Whitney test or ANOVA will be utilized to evaluate the level of significance in differentiation between the examined groups.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Sicily
-
Messina, Sicily, Italy, 98123
- IRCCS Centro Neurolesi "Bonino-Pulejo"
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients affected by PD;
- MMSE > 21
- Hoehn and Yahr <3
Exclusion Criteria:
- Presence of severe cognitive deficit
- Severe motor impairment (Hoehn and Yahr >3)
- Medical illness potentially interfering with the training
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental group
The investigators will enroll 30 patients with PD, randomly divided into two groups: (A) gait training with Music; (B) conventional treadmill gait training.
The 15 patients in the experimental group will perform training by means of the device Gait Trainer 3 (Biodex), where they will train on a tredmill equipped with music.
They will walk following specific musical beets and rhythms so to entrain their own internal rhythm.
Subjects will attend 3 sessions a week for at least 4 weeks.
Each session will last 45-min.
|
With the BIODEX Gait Trainer 3, patients acquire a smooth gait pattern.
In addition, balance, coordination, endurance and the cardiovascular system are trained.
Work on the treadmill strengthens the leg muscles.
On the screen or via an audio message, the patients and therapists receive direct feedback on the smoothness of the gait pattern.
The therapists can then make corrective interventions if necessary and the patients are motivated.
Other Names:
|
|
Active Comparator: Control Group
The control group will perform only conventional gait treadmill training, besides physical exercises to improve muscle force and tone.
Subjects will attend 3 sessions a week for at least 4 weeks.
Each session will last 45-min.
|
With the BIODEX Gait Trainer 3, patients acquire a smooth gait pattern.
In addition, balance, coordination, endurance and the cardiovascular system are trained.
Work on the treadmill strengthens the leg muscles.
On the screen or via an audio message, the patients and therapists receive direct feedback on the smoothness of the gait pattern.
The therapists can then make corrective interventions if necessary and the patients are motivated.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ten meters walking test
Time Frame: about 4 weeks
|
It is a performance measure used to assess walking speed in metres per second over a short distance.
It can be employed to determine functional mobility, gait, and vestibular function.
|
about 4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Electroencephalogram
Time Frame: about 4 weeks
|
It can be employed to evaluate the improvement in functional connectivity, i.e. the dinamic relation between different brain areas.
|
about 4 weeks
|
Collaborators and Investigators
Investigators
- Study Director: Placido Bramanti, MD, IRCCS Neurolesi
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 12/2017
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
Bezmialem Vakif UniversityRecruitingParkinson Disease | Parkinson | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseTurkey (Türkiye)
-
CND Life SciencesDigestive Disease Associates of CTRecruitingParkinson Disease | Parkinson | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Neuron23 Inc.Roche Diagnostic Ltd.; Qiagen Manchester LimitedRecruitingParkinson Disease | Parkinson | Idiopathic Parkinson Disease | Parkinson Disease, Idiopathic | Early Parkinson Disease (Early PD)United States, Spain, Israel, Poland, Italy, United Kingdom
-
San Francisco Neurology and Sleep CenterNot yet recruitingPARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Haukeland University HospitalUniversity of Bergen; SPARK NSRecruitingParkinson Disease (PD) | Parkinson s DiseaseNorway
-
CND Life SciencesOregon Health and Science UniversityRecruitingParkinson Disease | Parkinson | Parkinson's Disease and Parkinsonism | PARKINSON DISEASE (Disorder)United States
-
Università degli Studi dell'InsubriaUniversidade Nova de Lisboa; Associazione Parkinson Insubria (AsPI), Section... and other collaboratorsRecruitingParkinson Disease | Parkinson | Parkinson Disease, Idiopathic | PARKINSON DISEASE (Disorder)Italy
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
Duke UniversityMedical University of South Carolina; Massachusetts General Hospital; Mayo Clinic and other collaboratorsNot yet recruitingGut Microbiota | Gut Microbiome | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Prodromal Parkinsons DiseaseUnited States
-
ProgenaBiomeWithdrawnParkinson Disease | Parkinsons Disease With Dementia | Parkinson-Dementia Syndrome | Parkinson Disease 2 | Parkinson Disease 3 | Parkinson Disease 4United States
Clinical Trials on Gait Trainer 3
-
Kuopio University HospitalCompleted
-
University of ZurichCompleted
-
Prasat Neurological InstituteMahidol UniversityUnknown
-
Rennes University HospitalMinistry of Health, FranceTerminatedStroke | HemiplegiaFrance
-
Spaulding Rehabilitation HospitalNortheastern UniversityTerminatedGait Re-training in Healthy Subjects | Gait Re-training in Stroke SurvivorsUnited States
-
Universita di VeronaCompletedRelapsing-Remitting Multiple SclerosisItaly
-
National Institute of Neurological Disorders and...WithdrawnParkinson's Disease
-
Saint Joseph Mercy Health SystemTerminatedMobility LimitationsUnited States
-
Medipol UniversityCompleted
-
Lite Run Inc.Minneapolis Veterans Affairs Medical Center; TREATUnknownStroke | Brain Injuries, Traumatic | Spinal Cord Injuries | Gait Disorders, Neurologic